JNJ-101556143 Formulation 3 clinical trials

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

This study is testing a new drug, HLD-0915, for men with advanced prostate cancer that has stopped responding to standard treatments. It aims to see if the drug is safe and effective in slowing down the cancer's growth.